S 3258: Aviation Medication Transparency Act of 2026
S 3258 in plain English: This bill requires the FAA to create, publish, and update annually a list of medications that pilots and air traffic controllers may safely take while holding a medical certification. The list must be posted on the FAA website and shared with people seeking a license or medical certification.
Stated purpose
This bill requires the FAA to compile and publicly publish a list of medications that pilots and air traffic controllers may safely use or be prescribed, so that aviation workers and trainees can clearly understand which medications are allowed, which are prohibited, and under what conditions approved medications may be used.
Key points
- Directs the FAA to compile and publish a list of medications safe for pilots and air traffic controllers to use
- Requires the list to be posted publicly on the FAA website
- Requires the list to be distributed to those seeking a flight license or medical certification
- Requires annual updates to the medication list
Arguments supporters make
- Pilots and controllers currently have no single clear public list of approved medications, which can lead to confusion, uninformed decisions, or people hiding health conditions out of fear — a transparency fix improves both safety and fairness.
- Making medication guidance publicly available and user-friendly helps people plan their medical care proactively, potentially keeping more qualified, healthy aviation professionals in the workforce.
- Requiring FAA to consult unions, training schools, medical associations, and general aviation groups ensures the list reflects real-world needs rather than being developed in isolation.
Arguments opponents make
- Publishing a fixed approved-medications list could create false confidence — pilots or controllers might assume a listed medication is always safe to use while flying, when individual reactions and combinations vary and the savings clause may not fully protect the public from such misuse.
- Annual or update-triggered revisions may not keep pace with rapidly changing pharmacology or newly identified risks, potentially leaving outdated guidance on a public website that aviation workers rely on.
- The broad stakeholder consultation requirement and the one-year deadline may be difficult for the FAA to meet simultaneously, potentially delaying or diluting the quality of the list if rushed to comply.
Tradeoffs
Greater transparency and accessibility for aviation workers comes with the tension that a simplified public list may be misread as a blanket guarantee of safety, while the FAA is explicitly shielded from liability if someone is harmed relying on it — shifting risk toward individual workers and the flying public.
Current status in Congress: Passed Senate.
NewsClear — neutral news & congressional tracking · Bill of the Week